129 related articles for article (PubMed ID: 31897226)
21. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G
Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
[TBL] [Abstract][Full Text] [Related]
22. MiR-205 enhances cisplatin sensitivity of glioma cells by targeting E2F1.
Li FF; Xing C; Wu LL; Xue F
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):299-306. PubMed ID: 29424887
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of miR-26b induces cisplatin resistance in nasopharyngeal carcinoma by repressing JAG1.
Shi L; Yin W; Zhang Z; Shi G
FEBS Open Bio; 2016 Dec; 6(12):1211-1219. PubMed ID: 28203521
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-181d is a tumor suppressor in human esophageal squamous cell carcinoma inversely regulating Derlin-1.
Li D; Shi M; Ji H; Chen G; Jiang H; Wang Z
Oncol Rep; 2016 Oct; 36(4):2041-8. PubMed ID: 27572270
[TBL] [Abstract][Full Text] [Related]
25. NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc.
Wang Y; Cheng J; Xie D; Ding X; Hou H; Chen X; Er P; Zhang F; Zhao L; Yuan Z; Pang Q; Wang P; Qian D
Cancer Commun (Lond); 2018 Jun; 38(1):33. PubMed ID: 29871674
[TBL] [Abstract][Full Text] [Related]
26. Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8.
Qiu F; Liu L; Lin Y; Yang Z; Qiu F
Anticancer Agents Med Chem; 2019; 19(8):1021-1028. PubMed ID: 30848215
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-125b inhibits cell proliferation and induces cell apoptosis in esophageal squamous cell carcinoma by targeting BMF.
Fan YX; Bian XH; Qian PD; Chen ZZ; Wen J; Luo YH; Yan PW; Zhang Q
Oncol Rep; 2018 Jul; 40(1):61-72. PubMed ID: 29749531
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
[TBL] [Abstract][Full Text] [Related]
29. Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE.
Jing R; Chen W; Wang H; Ju S; Cong H; Sun B; Jin Q; Chu S; Xu L; Cui M
Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G719-29. PubMed ID: 26316588
[TBL] [Abstract][Full Text] [Related]
30. Long Noncoding RNA FAM201A Mediates the Radiosensitivity of Esophageal Squamous Cell Cancer by Regulating ATM and mTOR Expression via miR-101.
Chen M; Liu P; Chen Y; Chen Z; Shen M; Liu X; Li X; Li A; Lin Y; Yang R; Ni W; Zhou X; Zhang L; Tian Y; Li J; Chen J
Front Genet; 2018; 9():611. PubMed ID: 30574162
[No Abstract] [Full Text] [Related]
31. miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2.
Zhou YW; Zhang H; Duan CJ; Gao Y; Cheng YD; He D; Li R; Zhang CF
Oncotarget; 2016 May; 7(21):30730-47. PubMed ID: 27120794
[TBL] [Abstract][Full Text] [Related]
32. E2F1-regulated DROSHA promotes miR-630 biosynthesis in cisplatin-exposed cancer cells.
Cao JX; Li SY; An GS; Mao ZB; Jia HT; Ni JH
Biochem Biophys Res Commun; 2014 Jul; 450(1):470-5. PubMed ID: 24909689
[TBL] [Abstract][Full Text] [Related]
33. miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR.
Zeng W; Zhu JF; Liu JY; Li YL; Dong X; Huang H; Shan L
Biomed Pharmacother; 2019 Mar; 111():476-484. PubMed ID: 30594787
[TBL] [Abstract][Full Text] [Related]
34. Up-regulated miR-548k promotes esophageal squamous cell carcinoma progression via targeting long noncoding RNA-LET.
Chen Z; Lin J; Wu S; Xu C; Chen F; Huang Z
Exp Cell Res; 2018 Jan; 362(1):90-101. PubMed ID: 29126868
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma through blockade of the LIMK1/cofilin signaling pathway by binding to LIMK1.
Yu HX; Wang XL; Zhang LN; Zhang J; Zhao W
Biomed Pharmacother; 2019 Jan; 109():751-761. PubMed ID: 30551528
[TBL] [Abstract][Full Text] [Related]
36. miR-18a promotes cell proliferation of esophageal squamous cell carcinoma cells by increasing cylin D1 via regulating PTEN-PI3K-AKT-mTOR signaling axis.
Zhang W; Lei C; Fan J; Wang J
Biochem Biophys Res Commun; 2016 Aug; 477(1):144-149. PubMed ID: 27291152
[TBL] [Abstract][Full Text] [Related]
37. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ
Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma.
Sun J; Song K; Feng X; Gao S
Biochem Biophys Res Commun; 2016 Apr; 473(2):363-9. PubMed ID: 26777997
[TBL] [Abstract][Full Text] [Related]
39. MiR-495 inhibits esophageal squamous cell carcinoma progression by targeting Akt1.
Mao Y; Li L; Liu J; Wang L; Zhou Y
Oncotarget; 2016 Aug; 7(32):51223-51236. PubMed ID: 27323412
[TBL] [Abstract][Full Text] [Related]
40. miR-145 Regulates the sensitivity of esophageal squamous cell carcinoma cells to 5-FU via targeting REV3L.
Chen Q; Hou J; Wu Z; Zhao J; Ma D
Pathol Res Pract; 2019 Jul; 215(7):152427. PubMed ID: 31072625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
